Dec 07, 2016 23:00 pm UTC| Business
SOUTH BURLINGTON, Vt., Dec. 07, 2016 -- Dynapower Company and Samsung SDI announce the introduction of an integrated behind-the-meter energy storage system built on their respective proven technologies. The initial...
Nexeo Solutions, Inc. Reports Fourth Quarter and Fiscal Year 2016 Financial Results
Dec 07, 2016 22:27 pm UTC| Business
Fiscal Year 2016 Highlights (Versus Fiscal Year 2015) Fiscal year net loss for the Successor of $8 million and net loss from continuing operations of $14 million for the Predecessor for 2016 compared to net income from...
The Emma Bowen Foundation to Ring The Nasdaq Stock Market Closing Bell
Dec 07, 2016 22:14 pm UTC| Business
ADVISORY, Dec. 07, 2016 -- What:The Emma Bowen Foundation (EBF) is a non-profit organization founded in 1989 that focuses on increasing diversity in media and technology across all functions and levels. We do this by...
Covisint Launches Supplier Engagement Platform for SAIC General Motors and NextEV in China
Dec 07, 2016 22:00 pm UTC| Business
DETROIT and SHANGHAI, China, Dec. 07, 2016 -- Covisint Corporation (Nasdaq:COVS) today announced that it has signed agreements with Chinese automotive OEMs, SAIC General Motors (SGM) and NextEV to launch supplier...
Dec 07, 2016 21:50 pm UTC| Business
PRINCETON, N.J., Dec. 07, 2016 -- Equinox Fund Management, LLC (“Equinox”) — an innovator in alternative investments — today announces the agreement of sale of the Equinox Frontier Funds (“Frontier Funds”), a group of...
MCBC Holdings, Inc. Commences Proposed Secondary Offering of Common Stock
Dec 07, 2016 21:42 pm UTC| Business
VONORE, Tenn., Dec. 07, 2016 -- MCBC Holdings, Inc. (NASDAQ:MCFT) (the “Company”) today announced that it has commenced a secondary offering (the “Offering”) of the Company’s common stock held by affiliates of Wayzata...
Argos Therapeutics Reports Highlights from Investor Day in New York City
Dec 07, 2016 21:30 pm UTC| Business
DURHAM, N.C., Dec. 07, 2016 -- Argos Therapeutics Inc. (Nasdaq:ARGS) (“Argos”), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis®...